✦ LIBER ✦

Unfractionated Heparin Use After Percutaneous Coronary Intervention: Results of a Trial with a Vascular Ultrasound Endpoint

✍ Scribed by Craig P. Juergens; John A. Crozier; Jacqui T.C. Robinson; Sidney Lo; John K. French; Dominic Y.C. Leung

Book ID: 119255068
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 98 KB
Volume: 17
Category: Article
ISSN: 1443-9506
DOI: 10.1016/j.hlc.2007.07.011

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of 6 and 7 French guiding cat

Comparison of 6 and 7 French guiding catheters for percutaneous coronary intervention: Results of a randomised trial with a vascular ultrasound endpoint

✍ Craig P. Juergens; Hisham Hallani; Dominic Y.C. Leung; John A. Crozier; Jacqui T 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 2 views

Heparin after percutaneous intervention

Heparin after percutaneous intervention (HAPI): a prospective multicenter randomized trial of three heparin regimens after successful coronary intervention

✍ Maher Rabah; Denise Mason; David W.M Muller; Randal Hundley; Aaron D Kugelmass; 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 292 KB

A Direct Comparison of Intravenous Enoxa

A Direct Comparison of Intravenous Enoxaparin With Unfractionated Heparin in Primary Percutaneous Coronary Intervention (from the ATOLL Trial)

✍ Collet, Jean-Philippe; Huber, Kurt; Cohen, Marc; Zeymer, Uwe; Goldstein, Patrick 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 537 KB

Fondaparinux with UnfracTionated heparin

Fondaparinux with UnfracTionated heparin dUring Revascularization in Acute coronary syndromes (FUTURA/OASIS 8): A randomized trial of intravenous unfractionated heparin during percutaneous coronary intervention in patients with non–ST-segment elevation acute coronary syndromes initially treated with fondaparinux

✍ Philippe Gabriel Steg; Shamir Mehta; Sanjit Jolly; Denis Xavier; Hans-Juergen Ru 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 195 KB

Low molecular weight heparin (reviparin)

Low molecular weight heparin (reviparin) in percutaneous transluminal coronary angioplasty results of a randomized, double-blind, unfractionated heparin and placebo-controlled, multicenter trial (REDUCE trial)

✍ Karl R. Karsch; Melitta B. Preisack; Rainer Baildon; Volker Eschenfelder; David 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 877 KB

Evaluation of a New Heparin Agent in Per

Evaluation of a New Heparin Agent in Percutaneous Coronary Intervention: Results of the Phase 2 Evaluation of M118 IN pErcutaNeous Coronary intErvention (EMINENCE) Trial

✍ Rao, S. V.; Melloni, C.; Myles-DiMauro, S.; Broderick, S.; Kosinski, A. S.; Klei 📂 Article 📅 2010 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 639 KB